Delivery Order SPE2DB20D2104-SPE2DB25FMXVD
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lamotrigine ODT 200 mg tablets in quantities of 30 units, valued at $1,269.11. This firm fixed-price delivery order, set to be completed by August 8, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The award was competitively awarded without set-aside provisions, reflecting the vendor's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lamotrigine ODT 100 mg tablets (30-unit quantity) under a firm fixed-price contract valued at $11,986.07. This non-set-aside competitive award represents a single delivery order for this generic neurological medication, with an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Lamotrigine ER 200 mg tablets in 30-count quantities. This contract, valued at $1,133.76, represents a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,156.56 firm fixed-price contract is for the supply of Lamotrigine ODT 200 mg tablets, a prescription medication, to support military treatment programs and facilities. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lamotrigine ER 200 mg tablets in a 30-count package, with a ceiling value of $1,516.80 and a firm fixed price structure. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime contract vehicle valued through December 2026 that provides...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lamotrigine ER 300 mg tablets in a quantity of 30 units, valued at $2,357.64. This delivery order represents a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Lamotrigine ER 100 mg tablets in quantities of 30 units, with a ceiling value of $1,163.95. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 4, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open competition among...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,444.38 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ODT (orally disintegrating tablets) 50 mg in quantities of 30 tablets. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting the open competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 200 mg tablets (30-count units) on August 26, 2025, with a ceiling value of $1,004.61. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate completion date for this delivery order is August 27,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,463.94 firm fixed-price delivery order is for the supply of Lamotrigine ODT 200 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of October 24, 2022 and was awarded on October 21, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...